Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTB Bacteriophage for Pouchitis
NCT07878026Phase 1Not yet recruiting
- Sponsor
- Jinling Hospital
- Start
- Jan 2027
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in pouchitis, sponsored by Jinling Hospital. Primary endpoint: Percentage of participants with a decrease in Modified Pouchitis Disease Activity Index total score at 14 weeks. Planned start Jan 2027; status: not yet recruiting.
02
Conditions
pouchitis
Beyond the preview
Go deeper on NCT07878026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878026.